DYNAVAX TECHNOLOGIDYNAVAX TECHNOLOGIDYNAVAX TECHNOLOGI

DYNAVAX TECHNOLOGI

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.34 B‬CHF
‪−5.38 M‬CHF
‪195.57 M‬CHF
‪130.25 M‬
Beta (1Y)
−0.07

About Dynavax Technologies Corporation

CEO
Ryan Spencer
Headquarters
Emeryville
Employees (FY)
408
Founded
1996
FIGI
BBG00LVD85Y3
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DYF1 is 9.640 CHF — it has decreased by 11.19% in the past 24 hours. Watch DYNAVAX TECHNOLOGI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange DYNAVAX TECHNOLOGI stocks are traded under the ticker DYF1.
DYF1 stock has fallen by 11.19% compared to the previous week, the month change is a 12.36% fall, over the last year DYNAVAX TECHNOLOGI has showed a 1.14% increase.
We've gathered analysts' opinions on DYNAVAX TECHNOLOGI future price: according to them, DYF1 price has a max estimate of 26.18 CHF and a min estimate of 18.05 CHF. Watch DYF1 chart and read a more detailed DYNAVAX TECHNOLOGI stock forecast: see what analysts think of DYNAVAX TECHNOLOGI and suggest that you do with its stocks.
DYF1 reached its all-time high on Aug 31, 2021 with the price of 17.883 CHF, and its all-time low was 9.116 CHF and was reached on Mar 7, 2022. View more price dynamics on DYF1 chart.
See other stocks reaching their highest and lowest prices.
DYF1 stock is 12.81% volatile and has beta coefficient of −0.07. Track DYNAVAX TECHNOLOGI stock price on the chart and check out the list of the most volatile stocks — is DYNAVAX TECHNOLOGI there?
Today DYNAVAX TECHNOLOGI has the market capitalization of ‪1.32 B‬, it has increased by 2.00% over the last week.
Yes, you can track DYNAVAX TECHNOLOGI financials in yearly and quarterly reports right on TradingView.
DYNAVAX TECHNOLOGI is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
DYF1 earnings for the last quarter are −0.06 CHF per share, whereas the estimation was −0.02 CHF resulting in a −196.92% surprise. The estimated earnings for the next quarter are 0.06 CHF per share. See more details about DYNAVAX TECHNOLOGI earnings.
DYNAVAX TECHNOLOGI revenue for the last quarter amounts to ‪45.82 M‬ CHF, despite the estimated figure of ‪49.59 M‬ CHF. In the next quarter, revenue is expected to reach ‪68.88 M‬ CHF.
DYF1 net income for the last quarter is ‪−7.87 M‬ CHF, while the quarter before that showed ‪184.38 K‬ CHF of net income which accounts for ‪−4.37 K‬% change. Track more DYNAVAX TECHNOLOGI financial stats to get the full picture.
No, DYF1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 29, 2024, the company has 408.00 employees. See our rating of the largest employees — is DYNAVAX TECHNOLOGI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DYNAVAX TECHNOLOGI EBITDA is ‪−12.19 M‬ CHF, and current EBITDA margin is −11.53%. See more stats in DYNAVAX TECHNOLOGI financial statements.
Like other stocks, DYF1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DYNAVAX TECHNOLOGI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DYNAVAX TECHNOLOGI technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DYNAVAX TECHNOLOGI stock shows the sell signal. See more of DYNAVAX TECHNOLOGI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.